Section 801 – Enforcement — Fine — Citation.
Effective 12/3/2018 4-41a-801. Enforcement — Fine — Citation. (1) If a person that is a cannabis production establishment or a cannabis production establishment agent violates this chapter, the department may: (a) revoke the person’s license or cannabis production establishment agent registration card; (b) decline to renew the person’s license or cannabis production establishment agent registration […]
Section 802 – Report.
Effective 3/21/2022 4-41a-802. Report. (1) At or before the November interim meeting each year, the department shall report to the Health and Human Services Interim Committee on: (a) the number of applications and renewal applications that the department receives under this chapter; (b) the number of each type of cannabis production facility that the department […]
Section 901 – Academic medical cannabis research — License.
Effective 3/17/2021 4-41a-901. Academic medical cannabis research — License. (1) A medical cannabis research licensee may, subject to department rules described in Subsection (4), obtain from a cannabis production establishment or a medical cannabis pharmacy, and possess cannabis for academic medical cannabis research. (2) The department shall license a research university to obtain and possess […]
Section 902 – Cannabis production establishment product for academic research.
Effective 9/23/2019 4-41a-902. Cannabis production establishment product for academic research. A cannabis production establishment may sell cannabis and cannabis products to a medical cannabis research licensee for the purpose of academic research. Enacted by Chapter 5, 2019 Special Session 1
Section 903 – Unlawful acts.
Effective 9/23/2019 4-41a-903. Unlawful acts. (1) It is unlawful for a person who is not operating under the license of a medical cannabis research licensee to obtain or possess cannabis for academic medical cannabis research. (2) It is unlawful for a cannabis production establishment to offer, sell, or otherwise provide cannabis or cannabis products for […]
Section 602 – Cannabis product — Labeling and child-resistant packaging.
Effective 3/23/2022 4-41a-602. Cannabis product — Labeling and child-resistant packaging. (1) For any cannabis product that a cannabis processing facility processes or produces and for any raw cannabis that the facility packages, the facility shall: (a) label the cannabis or cannabis product with a label that: (i) clearly and unambiguously states that the cannabis product […]
Section 603 – Cannabis product — Product quality.
Effective 3/23/2022 4-41a-603. Cannabis product — Product quality. (1) A cannabis processing facility: (a) may not produce a cannabis product in a physical form that: (i) the facility knows or should know appeals to children; (ii) is designed to mimic or could be mistaken for a candy product; or (iii) for a cannabis product used […]
Section 701 – Cannabis and cannabis product testing.
Effective 3/23/2022 4-41a-701. Cannabis and cannabis product testing. (1) In accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, the department may make rules to: (a) determine required adulterant tests for a cannabis plant product, cannabis concentrate, or cannabis product; (b) determine the amount of any adulterant that is safe for human consumption; (c) […]
Section 702 – Reporting — Inspections — Seizure by the department.
Effective 3/17/2021 4-41a-702. Reporting — Inspections — Seizure by the department. (1) If an independent cannabis testing laboratory determines that the results of a lab test indicate that a cannabis or cannabis product batch may be unsafe for human use: (a) the independent cannabis testing laboratory shall report the results and the cannabis or cannabis […]
Section 404 – Medical cannabis transportation.
Effective 2/28/2020 4-41a-404. Medical cannabis transportation. (1) (a) Only the following individuals may transport cannabis or a cannabis product under this chapter: (i) a registered cannabis production establishment agent; or (ii) a medical cannabis cardholder who is transporting a medical cannabis treatment that the cardholder is authorized to possess under this chapter. (b) Only an […]